Navigation Links
Lilly and BioMS Medical Announce Global Licensing and Development Agreement
Date:12/17/2007

Lilly to Acquire Exclusive Rights to Novel Late-Stage Molecule for the

Treatment of Multiple Sclerosis

INDIANAPOLIS and EDMONTON, Alberta, Dec. 17 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and BioMS Medical Corp. (TSX: MS) today announced that the two companies have entered into a licensing and development agreement granting Lilly exclusive worldwide rights to BioMS Medical's lead multiple sclerosis (MS) compound, MBP8298. The compound is currently being evaluated in two pivotal phase III clinical trials in secondary progressive MS (SPMS) and one phase II clinical trial in relapsing-remitting MS (RRMS).

Under the terms of the agreement, Lilly and BioMS Medical will collaborate on the development of MBP8298 and will also share in certain development costs with Lilly being responsible for future R&D, manufacturing and marketing activities. BioMS Medical will receive an upfront payment of $87 million, as well as potential development and sales milestones up to $410 million and escalating royalties on sales commensurate with the current stage of development of the product if MBP8298 is successfully commercialized. BioMS Medical will continue to oversee the current clinical trials. Other terms of the deal were not disclosed.

"Lilly is pleased to add yet another promising late-stage compound to our portfolio," said Dr. William W. Chin, M.D., vice president of discovery research and clinical investigation for Lilly. "Multiple sclerosis is a disease with significant unmet patient needs. MBP8298 has shown potential in slowing the progression of secondary progressive MS, and thus may provide an effective therapeutic option for patients with this debilitating disease. We are also hopeful t
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. BioMS Medical announces its intention to renew a normal course issuer bid
5. BioMS Medical to present at BioContact 2007
6. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
7. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
8. BioMS Medical announces third quarter 2007 results
9. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
10. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
11. AEterna Zentaris completes management team with the appointment of Chief Medical Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...-FirstCall/ -- Omeros Corporation (Nasdaq: OMER )...he third quarter ended September 30, 2009. For the...orted a net loss of $3.9 million, or $1.34 per sha...$2.54 per share, for the same period in 2008. For ...any reported a net loss of $15.5 million, or $5.29...
(Date:11/19/2009)...wswire-FirstCall/ -- Spherix Incorporated (Nasdaq:...es therapy, and a provider of technical and regula...echnology and pharmaceutical companies, today anno...hareholders. ,, At the meeting, shareholders of... following members to the Board of Directors: ,...
(Date:11/19/2009)...geons and recognized refractive and cataract surge...rought their fellow surgeons up-to-date on the lat...aract surgery, and ophthalmology in general at the...ogy (AAO) annual meeting in San Francisco, Califor.... David Huang, MD, Dr. Randy Epstein, Dr. William ...
(Date:11/18/2009)...swire/ -- Marrone Bio Innovations (MBI), a leader ...n of effective and environmentally responsible pes...named an IC20 company by the Investors, Circle, th... investing group. ,, Companies named to the IC2...s for all stakeholders, including investors, the e...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Marrone Bio Innovations Named an IC20 Company 2
...and INDIANAPOLIS, Feb. 23 Heart patients with acu...ening procedure will soon have a new treatment opt... Company, Limited (TSE: 4568) and Eli Lilly and Co...pean Commission has granted marketing authorizatio...l) for the prevention of atherothrombotic events...
...BBOTT PARK, Ill., Feb. 23 In 2008, Abbott,s,( NY... new company records both,in terms of number of pa...ns,despite difficult economic times. Nearly three...articipated in the company,s employee giving progr...contributed more than $12.6,million to non-profit ...
... iCardiac Continues to Successfu...fering , Rochester, New Y...gies, Inc., a leading innovator in advanced cardia...y announced that the company has experienced signi...revenues have grown in excess of 100%. Pharmaceut...
Other Biology Technology:European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 2European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 3European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 4European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 5Abbott Employee Giving Sets New Records for Employee Participation and Total Donations 2Abbott Employee Giving Sets New Records for Employee Participation and Total Donations 3iCardiac Reports Significant Revenue Growth and Profitability 2iCardiac Reports Significant Revenue Growth and Profitability 3
(Date:11/19/2009)...vey of genetic diversity in maize, also known as c...veloped a gene map that should pave the way to sig...ource of food, fuel, animal feed and fiber around ... map known as a haplotype map, charts genetic dive...bred lines of maize. The research team, led by U.S...
(Date:11/19/2009)...nn State,s Ross Hardison, T. Ming Chu Professor of...arge step toward unraveling how regulatory protein...evelopment and growth. Working with collaborators ...hildren,s Hospital of Philadelphia, they focused s...d blood cells (erythrocytes). These cells contain ...
(Date:11/19/2009)...vember 19, 2009 A team led by scientists at The Sc...link between insulina hormone long associated with...esand core body temperature. While much research h...n the 1920s, this is the first time the hormone ha...perature regulation. , The paper was published r...
Breaking Biology News(10 mins):New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Scripps research scientists find new link between insulin and core body temperature 2Scripps research scientists find new link between insulin and core body temperature 3Scripps research scientists find new link between insulin and core body temperature 4No Gender Gap Found for Clot Busting Drug 61018 1No Gender Gap Found for Clot Busting Drug 61018 2No Gender Gap Found for Clot Busting Drug 61018 3Handwriting Skills May Lag in Kids With Autism 61014 1Handwriting Skills May Lag in Kids With Autism 61014 2Glamour Magazine Woman of the Year and MISSION Skincare Co Founder Serena Williams Teams Up with CVS pharmacy to Launch National Active Lifestyle Sk 6100 1Glamour Magazine Woman of the Year and MISSION Skincare Co Founder Serena Williams Teams Up with CVS pharmacy to Launch National Active Lifestyle Sk 6100 2Glamour Magazine Woman of the Year and MISSION Skincare Co Founder Serena Williams Teams Up with CVS pharmacy to Launch National Active Lifestyle Sk 6100 3
...r is delighted to announce the publication of a un...es and Screening in the Prevention of Cervical Can...ve and invaluable update for paediatricians, gynae...s, industry and major donor institutions worldwide...HPV) vaccines and the progressive introduction of ...
...that some stealthy mammals have been doing somethi...e of smell under water. , The results of the resea...fessor of biology, were reported Dec. 21 in the sc...served that a mole he was studying blew a lot of b...surprise because the common wisdom is that mammals...
...th short-term structural changes in cognitive area...d in the January 1, 2007 issue of CANCER ( http://...er-reviewed journal of the American Cancer Society...ving adjuvant chemotherapy, significant regions of...her cognitive functions were significantly smaller...
Other Biology News:Contrary to common wisdom, scientist discovers some mammals can smell objects under water 2Contrary to common wisdom, scientist discovers some mammals can smell objects under water 3Chemotherapy temporarily affects the structures of the human brain 2
Goat Anti-Fibulin-2 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Abin-2 (N-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-C. elegans Syd-2 (cL-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Human Dysadherin 2 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: